Drugs and Acute Porphyrias: Reasons for a Hazardous Relationship

References

• . Kauppinen R. Porphyrias. Lancet. 2005;365(9455):241–252
   PubMed Web of Science ®Google Scholar
• . Puy H, Gouya L. Deybach JC. Porphyrias. Lancet. 2010;375(9718):924–937
   PubMed Web of Science ®Google Scholar
• . Ventura P. Le Porfirie. In: Brunetti P, Santeusanio F, eds. Trattato di Medicina Interna. Vol Malattie delle Ghiandole Endocrine, del Metabolismo e della Nutrizione. Padova: Piccin Nuova Libraria; 2011:931–952
   Google Scholar
• . Desnick R. Porfirie. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison principi di medicina interna, 15th ed. Milan: McGraw-Hill; 2002
   Google Scholar
• . Elder GH, Hift RJ. Treatment of acute porphyria. Hosp Med. 2001;62(7):422–425
   PubMedGoogle Scholar
• . Ventura P, Cappellini MD, Rocchi E. The acute porphyrias: a diagnostic and therapeutic challenge in internal and emergency medicine. Intern Emerg Med. 2009;4(4):297–308
   PubMed Web of Science ®Google Scholar
• . Thunell S. Porphyrins, porphyrin metabolism and porphyrias. I. Update. Scand J Clin Lab Invest. 2000;60(7):509–540
   PubMed Web of Science ®Google Scholar
• . Moore MR, Hift RJ. Drugs in the acute porphyrias—toxicogenetic diseases. Cell Mol Biol. 1997;43(1):89–94
   PubMed Web of Science ®Google Scholar
• . Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. Biochim Biophys Acta. 2006;1763(7):723–736
   PubMed Web of Science ®Google Scholar
• . Heinemann IU, Jahn M, Jahn D. The biochemistry of heme biosynthesis. Arch Biochem Biophys. 2008;474(2):238–251
   PubMed Web of Science ®Google Scholar
• . Ponka P. Cell biology of heme. Am J Med Sci. 1999;318(4):241–256
   PubMed Web of Science ®Google Scholar
• . Leeper FJ. The biosynthesis of porphyrins, chlorophylls, and vitamin B12. Nat Prod Rep. 1989;6(2):171–203
   PubMed Web of Science ®Google Scholar
• . James MF, Hift RJ. Porphyrias. Br J Anaesth. 2000;85(1):143–153
   PubMed Web of Science ®Google Scholar
• . Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60(1):79–127
   PubMed Web of Science ®Google Scholar
• . Abraham NG, Lin JH, Schwartzman ML, Levere RD, Shibahara S. The physiological significance of heme oxygenase. Int J Biochem. 1988;20(6):543–558
   PubMedGoogle Scholar
• . McCoubrey WK Jr, Maines MD. The structure, organization and differential expression of the gene encoding rat heme oxygenase-2. Gene. 1994;139(2):155–161
   PubMed Web of Science ®Google Scholar
• . Shibahara S, Yoshizawa M, Suzuki H, Takeda K, Meguro K, Endo K. Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J Biochem. 1993;113(2):214–218
   PubMed Web of Science ®Google Scholar
• . Muller RM, Taguchi H, Shibahara S. Nucleotide sequence and organization of the rat heme oxygenase gene. J Biol Chem. 1987;262(14):6795–6802
   PubMed Web of Science ®Google Scholar
• . McCoubrey WK Jr, Ewing JF, Maines MD. Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal. Arch Biochem Biophys. 1992;295(1):13–20
   PubMed Web of Science ®Google Scholar
• . Li C, Hossieny P, Wu BJ, Qawasmeh A, Beck K, Stocker R. Pharmacologic induction of heme oxygenase-1. Antioxidants Redox Signaling. 2007;9(12):2227–2239
   PubMed Web of Science ®Google Scholar
• . Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 1997;89(1):1–25
   PubMed Web of Science ®Google Scholar
• . May BK, Dogra SC, Sadlon TJ, Bhasker CR, Cox TC, Bottomley SS. Molecular regulation of heme biosynthesis in higher vertebrates. Prog Nucl Acid Res Mol Biol. 1995;51:1–51
   PubMedGoogle Scholar
• . Yoshino K, Munakata H, Kuge O, Ito A, Ogishima T. Haeme-regulated degradation of delta-aminolevulinate synthase 1 in rat liver mitochondria. J Biochem. 2007;142(4):453–458
   PubMed Web of Science ®Google Scholar
• . Ponka P, Schulman HM. Regulation of heme biosynthesis: distinct regulatory features in erythroid cells. Stem Cells. 1993;11( Suppl 1):24–35
   PubMed Web of Science ®Google Scholar
• . Ponka P, Schulman HM. Regulation of heme synthesis in erythroid cells: hemin inhibits transferrin iron utilization but not protoporphyrin synthesis. Blood. 1985;65(4):850–857
   PubMed Web of Science ®Google Scholar
• . Ponka P, Schulman HM. Distinct features of iron metabolism in erythroid cells: implications for heme synthesis regulation. Adv Exp Med Biol. 1994;356:173–187
   PubMedGoogle Scholar
• . Abraham N, Friedland M, Levere R. Heme metabolism in hepatic and erythroid cells. In: Brown E, ed. Progress in Hematology. New York: Grune & Stratton; 1983:75–130
   Google Scholar
• . Ventura E, Rocchi E. Le Porfirie. In: Guarini G, Fiorelli G, Malliani A, Violi E, Volpe M, eds. Teodori 2000. Trattato di Medicina Interna, Vol 2, 6th ed. Rome: Società Editrice Universo; 2001:2301–2334
   Google Scholar
• . Gross U, Hoffmann GF, Doss MO. Erythropoietic and hepatic porphyrias. J Inherit Metabol Dis. 2000;23(7):641–661
   PubMed Web of Science ®Google Scholar
• . Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: diagnosis and management. Clin Liver Dis. 2004;8(4):807–838, viii
   PubMedGoogle Scholar
• . Dombeck TA, Satonik RC. The porphyrias. Emerg Med Clin North Am. 2005;23(3):885–899
   PubMed Web of Science ®Google Scholar
• . Poblete-Gutierrez P, Wiederholt T, Merk HF, Frank J. The porphyrias: clinical presentation, diagnosis and treatment. Eur J Dermatol. 2006;16(3):230–240
   PubMed Web of Science ®Google Scholar
• . Canavese C, Gabrielli D, Guida C, Cappellini MD. [Nephrologists and porphyrias]. G Ital Nefrol. 2002;19(4):393–412
   PubMedGoogle Scholar
• . Thunell S, Pomp E, Brun A. Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias. Br J Clin Pharmacol. 2007;64(5):668–679
   PubMed Web of Science ®Google Scholar
• . Gorchein A. Drug treatment in acute porphyria. Br J Clin Pharmacol. 1997;44(5):427–434
   PubMed Web of Science ®Google Scholar
• . Deybach JC. Porphyria. Painful photosensitivity. Lancet. 2001;358( Suppl):S49
   Google Scholar
• . Jose J, Saravu K, Shastry BA, Jimmy B. Drug use in porphyria: a therapeutic dilemma. Singapore Med J. 2008;49(10):e272–e275
   PubMed Web of Science ®Google Scholar
• . Sassa S. Gene-environmental interactions: lessons from porphyria. Environ Health Prev Med. 2003;7(6):254–263
   PubMedGoogle Scholar
• . Fraser DJ, Podvinec M, Kaufmann MR, Meyer UA. Drugs mediate the transcriptional activation of the 5-aminolevulinic acid synthase (ALAS1) gene via the chicken xenobiotic-sensing nuclear receptor (CXR). J Biol Chem. 2002;277(38):34717–34726
   PubMed Web of Science ®Google Scholar
• . Podvinec M, Handschin C, Looser R, Meyer UA. Identification of the xenosensors regulating human 5-aminolevulinate synthase. Proc Natl Acad Sci USA. 2004;101(24):9127–9132
   PubMed Web of Science ®Google Scholar
• . Porphyria South Africa online. http://www.porphyria.uct.ac.za
   Google Scholar
• . Epnet. European Porphyria Network. http://www.porphyria-europe.com
   Google Scholar
• . Brodie MJ. Drug safety in porphyria. Lancet. 1980;2(8185):86
   PubMed Web of Science ®Google Scholar
• . NAPOS. The Drug Database for Acute Porphyria. http://www.drugs-porphyria.org
   Google Scholar
• . Larrey D, Tinel M, Letteron P, Geneve J, Descatoire V, Pessayre D. Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters. Biochem Pharmacol. 1986;35(13):2213–2220
   PubMed Web of Science ®Google Scholar
• . Green-Thompson RP, Riddick DS, Mackie JE, Marks GS, Halpert JR. Porphyrinogenic effects in chick embryo liver cell culture of chloramphenicol analogues that are mechanism-based inactivators of cytochrome P-450. Can J Physiol Pharmacol. 1991;69(4):526–530
   PubMed Web of Science ®Google Scholar
• . Zhao XJ, Jones DR, Wang YH, Grimm SW, Hall SD. Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolites. Xenobiotica. 2002;32(10):863–878
   PubMed Web of Science ®Google Scholar
• . American Porphyria Foundation. http://www.porphyriafoundation.com
   Google Scholar
• . Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol. 2008;82(10):667–715
   PubMed Web of Science ®Google Scholar
• . Handschin C, Lin J, Rhee J,. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell. 2005;122(4):505–515
   PubMed Web of Science ®Google Scholar
• . DeLoskey RJ, Beattie DS. The effects of insulin and glucose on the induction and intracellular translocation of delta-aminolevulinic acid synthase. Arch Biochem Biophys. 1984;233(1):64–71
   PubMed Web of Science ®Google Scholar
• . Martini CN, Romero DG, Yanes LL, Vila Mdel C. Induction of 5-aminolevulinate synthase by activators of steroid biosynthesis. Life Sci. 2007;81(1):19–25
   PubMed Web of Science ®Google Scholar
• . Giger U, Meyer UA. Induction of delta-aminolevulinate synthase and cytochrome P-450 hemoproteins in hepatocyte culture. Effect of glucose and hormones. J Biol Chem. 1981;256(21):11182–11190
   PubMed Web of Science ®Google Scholar
• . Andersson C, Bylesjo I, Lithner F. Effects of diabetes mellitus on patients with acute intermittent porphyria. J Intern Med. 1999;245(2):193–197
   PubMed Web of Science ®Google Scholar
• . Rodriguez JA, Martinez Mdel C, Gerez E, Batlle A, Buzaleh AM. Heme oxygenase, aminolevulinate acid synthetase and the antioxidant system in the brain of mice treated with porphyrinogenic drugs. Cell Mol Biol. 2005;51(5):487–494
   PubMed Web of Science ®Google Scholar
• . Ferrandiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharmaceut Design. 2008;14(5):473–486
   PubMed Web of Science ®Google Scholar
• . Hift RJ, Thunell S, Brun A. Drugs in porphyria: From observation to a modern algorithm-based system for the prediction of porphyrogenicity. Pharmacol Ther. 2011;132(2):158–169
   PubMed Web of Science ®Google Scholar
• . Porphyria Australia. www.porphyria-australia.org
   Google Scholar
• . Associazione Italiana Malati di Porfiria. http://www.amapo.it
   Google Scholar
• . Asociación Española de Porfiria. http://porfiria.org
   Google Scholar
• . British Porphyria Association. http://www.porphyria.org.uk
   Google Scholar
• . Welsh Medicines Information Centre—Porphryria Information Centre. http://www.wmic.wales.nhs.uk/porphyria_info.php
   Google Scholar
• . Elder G, Harper P, Badminton M, Sandberg S, Deybach JC. The incidence of inherited porphyrias in Europe. J Inherit Metabol Dis. 2013;36(5):849–857
   PubMed Web of Science ®Google Scholar
• . Elder GH, Hift RJ, Meissner PN. The acute porphyrias. Lancet. 1997;349(9065):1613–1617
   PubMed Web of Science ®Google Scholar
• . Thunell S, Harper P, Brock A, Petersen NE. Porphyrins, porphyrin metabolism and porphyrias. II. Diagnosis and monitoring in the acute porphyrias. Scand J Clin Lab Invest. 2000;60(7):541–559
   PubMed Web of Science ®Google Scholar
• . Thunell S. (Far) Outside the box: genomic approach to acute porphyria. Physiol Res/Acad Scientiarum Bohemoslovaca. 2006;55( Suppl 2):S43–S66
   PubMed Web of Science ®Google Scholar
• . Lavandera JV, Parera VE, Batlle A, Buzaleh AM. CYP2D6 polymorphisms in patients with porphyrias. Mol Med. 2006;12(9–10):259–263
   PubMed Web of Science ®Google Scholar
• . Lavandera JV, Batlle AM, Buzaleh AM. Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney. Cell Mol Neurobiol. 2007;27(6):717–729
   PubMed Web of Science ®Google Scholar
• . Yoshida T, Biro P, Cohen T, Muller RM, Shibahara S. Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem/FEBS. 1988;171(3):457–461
   PubMedGoogle Scholar
• . Pimstone NR, Engel P, Tenhunen R, Seitz PT, Marver HS, Schmid R. Inducible heme oxygenase in the kidney: a model for the homeostatic control of hemoglobin catabolism. J Clin Invest. 1971;50(10):2042–2050
   PubMed Web of Science ®Google Scholar
• . Sardana MK, Kappas A. Dual control mechanism for heme oxygenase: tin(IV)-protoporphyrin potently inhibits enzyme activity while markedly increasing content of enzyme protein in liver. Proc Natl Acad Sci USA. 1987;84(8):2464–2468
   PubMed Web of Science ®Google Scholar
• . Grosser N, Abate A, Oberle S,. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun. 2003;308(4):956–960
   PubMed Web of Science ®Google Scholar
• . Choi BM, Kim YM, Jeong YR,. Induction of heme oxygenase-1 is involved in anti-proliferative effects of paclitaxel on rat vascular smooth muscle cells. Biochem Biophys Res Commun. 2004;321(1):132–137
   PubMed Web of Science ®Google Scholar
• . Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, Agarwal A. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation. 2003;107(6):911–916
   PubMed Web of Science ®Google Scholar
• . Lee TS, Chang CC, Zhu Y, Shyy JY. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation. 2004;110(10):1296–1302
   PubMed Web of Science ®Google Scholar
• . Loboda A, Jazwa A, Jozkowicz A,. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis. 2006;187(1):26–30
   PubMed Web of Science ®Google Scholar
• . Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol. 1996;270(1 Pt 2):H107–H114
   Google Scholar
• . Abdel Aziz MT, El-Asmer MF, Mostafa T,. Heme oxygenase vs. nitric oxide synthase in signaling mediating sildenafil citrate action. J Sex Med. 2007;4(4 Pt 2):1098–1107
   PubMed Web of Science ®Google Scholar
• . Sun J, Kim SJ, Park MK,. Selective activation of adrenergic beta1 receptors induces heme oxygenase 1 production in RAW264.7 cells. FEBS Lett. 2005;579(25):5494–5500
   PubMed Web of Science ®Google Scholar
• . Deng YM, Wu BJ, Witting PK, Stocker R. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation. 2004;110(13):1855–1860
   PubMed Web of Science ®Google Scholar
• . Pagnin E, Giacon B, Zaghetto F,. Arterial hypertension and oxidative stress induced by cyclosporin. Effect of carvedilol. Ann Ital Med Intern. 2001;16(2):101–105
   PubMedGoogle Scholar
• . Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2(10):2557–2568
   PubMed Web of Science ®Google Scholar
• . Smith TJ, Drummond GS, Kourides IA, Kappas A. Thyroid hormone regulation of heme oxidation in the liver. Proc Natl Acad Sci USA. 1982;79(23):7537–7541
   PubMed Web of Science ®Google Scholar
• . Ishizaka N, de Leon H, Laursen JB,. Angiotensin II-induced hypertension increases heme oxygenase-1 expression in rat aorta. Circulation. 1997;96(6):1923–1929
   PubMed Web of Science ®Google Scholar
• . Harrison EM, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ. Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J. 2006;273(11):2345–2356
   PubMed Web of Science ®Google Scholar
• . Immenschuh S, Kietzmann T, Hinke V, Wiederhold M, Katz N, Muller-Eberhard U. The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase A signaling pathway in rat hepatocyte cultures. Mol Pharmacol. 1998;53(3):483–491
   PubMed Web of Science ®Google Scholar
• . Cantoni L, Rossi C, Rizzardini M, Gadina M, Ghezzi P. Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J. 1991;279(Pt 3):891–894
   PubMed Web of Science ®Google Scholar
• . Kutty RK, Nagineni CN, Kutty G, Hooks JJ, Chader GJ, Wiggert B. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol. 1994;159(2):371–378
   PubMed Web of Science ®Google Scholar
• . Polte T, Hemmerle A, Berndt G, Grosser N, Abate A, Schroder H. Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1. Free Rad Biol Med. 2002;32(1):56–63
   PubMed Web of Science ®Google Scholar
• . Motterlini R, Green CJ, Foresti R. Regulation of heme oxygenase-1 by redox signals involving nitric oxide. Antioxidants Redox Signaling. 2002;4(4):615–624
   PubMed Web of Science ®Google Scholar
• . Gong P, Stewart D, Hu B,. Activation of the mouse heme oxygenase-1 gene by 15-deoxy-Delta(12,14)-prostaglandin J(2) is mediated by the stress response elements and transcription factor Nrf2. Antioxidants Redox Signaling. 2002;4(2):249–257
   PubMed Web of Science ®Google Scholar
• . Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am J Physiol Cell Physiol. 2005;289(3):C557–C563
   Web of Science ®Google Scholar
• . Sacerdoti D, Colombrita C, Di Pascoli M,. 11,12-epoxyeico-satrienoic acid stimulates heme-oxygenase-1 in endothelial cells. Prostagland Other Lipid Mediators. 2007;82(1–4):155–161
   PubMed Web of Science ®Google Scholar
• . Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol. 2000;60(8):1121–1128
   PubMed Web of Science ®Google Scholar
• . Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Rad Biol Med. 2000;28(8):1303–1312
   PubMed Web of Science ®Google Scholar
• . Liu LG, Yan H, Zhang W,. Induction of heme oxygenase-1 in human hepatocytes to protect them from ethanol-induced cytotoxicity. Biomed Environ Sci. 2004;17(3):315–326
   PubMed Web of Science ®Google Scholar
• . Chen C, Pung D, Leong V,. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Rad Biol Med. 2004;37(10):1578–1590
   PubMed Web of Science ®Google Scholar
• . Jeong WS, Keum YS, Chen C,. Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells. J Biochem Mol Biol. 2005;38(2):167–176
   PubMedGoogle Scholar
• . Chen CY, Jang JH, Li MH, Surh YJ. Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res Commun. 2005;331(4):993–1000
   PubMed Web of Science ®Google Scholar
• . Sorrenti V, Mazza F, Campisi A,. Heme oxygenase induction by cyanidin-3-O-beta-glucoside in cultured human endothelial cells. Mol Nutr Food Res. 2007;51(5):580–586
   PubMed Web of Science ®Google Scholar
• . Foresti R, Hoque M, Monti D, Green CJ, Motterlini R. Differential activation of heme oxygenase-1 by chalcones and rosolic acid in endothelial cells. J Pharmacol Exp Ther. 2005;312(2):686–693
   PubMed Web of Science ®Google Scholar
• . Scapagnini G, Foresti R, Calabrese V, Giuffrida Stella AM, Green CJ, Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol. 2002;61(3):554–561
   PubMed Web of Science ®Google Scholar
• . Chen JX, Zeng H, Chen X, Su CY, Lai CC. Induction of heme oxygenase-1 by Ginkgo biloba extract but not its terpenoids partially mediated its protective effect against lysophosphatidylcholine-induced damage. Pharmacol Res. 2001;43(1):63–69
   PubMed Web of Science ®Google Scholar
• . Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA. 1989;86(1):99–103
   PubMed Web of Science ®Google Scholar
• . Shibahara S, Muller RM, Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem. 1987;262(27):12889–12892
   PubMed Web of Science ®Google Scholar
• . Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest. 1997;100(3):589–596
   PubMed Web of Science ®Google Scholar
• . Gemsa D, Woo CH, Fudenberg HH, Schmid R. Stimulation of heme oxygenase in macrophages and liver by endotoxin. J Clin Invest. 1974;53(2):647–651
   PubMed Web of Science ®Google Scholar
• . Matsuura Y, Watanabe H, Fukuda T, Yoshida T, Kuroiwa Y. A sustained increase of microsomal heme oxygenase activity following treatment of rats with Bacillus Calmette-Guerin and Corynebacterium parvum: its possible relation to the decrease of cytochrome P-450 content. J Pharmacobio Dynam. 1985;8(8):669–678
   PubMedGoogle Scholar
• . Jordi-Racine AL, Alvarez E, Reichen J. The effect of hypoxia on hepatic cytochromes and heme turnover in rats in vivo. Experientia. 1988;44(4):343–345
   PubMedGoogle Scholar
• . Lee PJ, Alam J, Sylvester SL, Inamdar N, Otterbein L, Choi AM. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol. 1996;14(6):556–568
   PubMed Web of Science ®Google Scholar
• . Bakken AF, Thaler MM, Schmid R. Metabolic regulation of heme catabolism and bilirubin production. I. Hormonal control of hepatic heme oxygenase activity. J Clin Invest. 1972;51(3):530–536
   PubMed Web of Science ®Google Scholar
• . Maines MD, Kappas A. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc Natl Acad Sci USA. 1974;71(11):4293–4297
   PubMed Web of Science ®Google Scholar
• . Sardana MK, Drummond GS, Sassa S, Kappas A. The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals. Pharmacology. 1981;23(5):247–253
   PubMed Web of Science ®Google Scholar
• . Alam J, Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem. 1992;267(30):21894–21900
   PubMed Web of Science ®Google Scholar
• . Stout DL, Becker FF. Heme enzyme patterns in genetically and chemically induced mouse liver tumors. Cancer Res. 1986;46(6):2756–2759
   PubMed Web of Science ®Google Scholar
• . Disler PB, Blekkenhorst GH, Eales L, Moore MR, Straughan J. Guidelines for drug prescription in patients with the acute porphyrias. S Afr Med J. 1982;61(18):656–660
   PubMed Web of Science ®Google Scholar